Skip to main content
War in Gaza:: find out how we're responding
Learn more
7467 Results
 
msf-placeholder
HIV/AIDS

Children being neglected in AIDS fight, with paediatric AIDS medicines scarce

The estimated worldwide number of children with HIV/AIDS was over 2.5 million in 2003. In the same year, 700,000 children under the age of 15 were newly infected with HIV/AIDS, 88.6% of whom live in sub-Saharan Africa. Approximately 50% of children with HIV/AIDS die before the age of two. Press Release - 13 Jul 2004
 
msf-placeholder
HIV/AIDS

MSF reports on progress and challenges of expanding AIDS treatment programs

MSF provides antiretroviral treatment to more than 13,000 patients spread across 56 projects in 25 countries. MSF has been caring for people living with HIV/AIDS in developing countries since the mid 1990s, and the first MSF ARV treatment projects began in 2000 (in Thailand and South Africa). Press Release - 12 Jul 2004
 
msf-placeholder
Myanmar

Burma's neglected Aids babies given new hope

One child's salvation is a symbol of the stark ethical and economic choices facing doctors and scientists as they gather in Bangkok this weekend for the world's 15th International Aids Conference. Project Update - 11 Jul 2004
 
msf-placeholder
HIV/AIDS

Challenges of AIDS treatment are no excuse: treat now

The AIDS virus has spread with lightning speed across the world since 1983. 40 million people are now living with HIV and AIDS is the major cause of mortality in Africa. Project Update - 11 Jul 2004
 
msf-placeholder
Thailand

In Thailand, patient activism is crucial to expanding treatment

In December 1999, over 300 people with HIV/AIDS demonstrated outside the Public Health Ministry for three days, in support of a request by GPO for a compulsory license to allow it to make generic versions of the ARV didanosine (ddI). It was the first time in Thailand that HIV positive people had braved stigmatisation to stage public demonstrations and it proved to be a watershed event. Project Update - 11 Jul 2004
 
msf-placeholder
China

FDCs: fixing access problems

FDCs simplify treatment by significantly reducing the number of pills that need to be taken daily. As they are often made by generic companies, FDCs are also generally much cheaper than the single pills sold by originator companies. Project Update - 11 Jul 2004
 
msf-placeholder
Malawi

Hidden from view : monitoring ARV treatment failure

The problem is that detecting treatment failure at the proper time depends on sophisticated laboratory equipment often not available or affordable in poor countries like Malawi. Project Update - 11 Jul 2004
 
msf-placeholder
South Africa

Second-line ARV treatment: unaffordable luxury?

Xolani has been on antiretroviral treatment at MSF's clinic in Khayelitsha, South Africa, for three years - but now tests indicate that his treatment is failing. Project Update - 11 Jul 2004
 
msf-placeholder
Tuberculosis

TB in an HIV setting: double trouble

More effective and affordable diagnostic tests able to detect TB in HIV positive patients, including extra-pulmonary cases and among children. These tests need to be easy to use even where there is little infrastructure or training. Project Update - 11 Jul 2004
 
msf-placeholder
Ecuador

What is the cost for health care in Ecuador?

A new Presidential Decree threatens to place the commercial interests of the US and multinational pharmaceutical companies above the access to medicines of the Ecuadorian people Press Release - 2 Jul 2004
Cholera intervention in South Kivu
Médecins Sans Frontières (MSF)

Independent medical humanitarian assistance

We provide medical assistance to people affected by conflict, epidemics, disasters, or exclusion from healthcare. Our teams are made up of tens of thousands of health professionals, logistic and administrative staff - most of them hired locally. Our actions are guided by medical ethics and the principles of independence and impartiality. We are a non-profit, self-governed, member-based organisation.

Learn more